Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASPREE-AMD aspirin trial for age-related macular degeneration
ACTRN12613000755730Phase 3Recruiting
- Sponsor
- Monash University
- Start
- Jun 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in age-related macular degeneration (AMD) comparing Aspirin with Placebo (2 arms). Primary endpoints: Incidence of age-related macular degeneration, Progression in severity of non-advanced age-related macular degeneration and 1 more. Started Jun 2013; status: recruiting.
02
Drugs
aspirin
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on ACTRN12613000755730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000755730.